BUPIVACAINE HYDROCH
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This contract is for the procurement of Bupivacaine Hydrochloride Injection USP 0.5% in 50 ML vials, manufactured by Pfizer Inc under part number NDC00409-1163-18. The item is regulated by the FDA and must be stored at controlled room temperatures between 20 to 25 degrees Celsius. It carries a non-extendable shelf life of 24 months and must adhere to specific DLA technical, quality, and packaging requirements, including Medical Marking Standard No. 1 and MIL-STD-129. The order consists of one unit under NSN 6505001387347 with a delivery requirement of 10 days after receipt of order. The destination for delivery and inspection is the QM Support Company at Smith Barracks in Baumholder, Germany. This solicitation, identified as SPE2DP-26-T-4664, is managed by the Department of Defense Medical Supply Chain Pharmacy FSA and requires strict adherence to DLA packaging and hazardous material standards where applicable.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
BUPIVACAINE HYDROCHLORIDE INJECTION<(>,<)> USP, 0.5%, 50 ML. STORE AT 20
TO 25°C (68 TO 77°F).[SEE USP CONTROLLED ROOM TEMPERATURE].
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PFIZER INC 86491 P/N NDC00409-1163-18
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017891010 0001 VI 1.000
NSN/MATERIAL:6505001387347
DELIVERY (IN DAYS):0010
DELIVER FOB: DESTINATION
SPE2DP-26-T-4664
SECTION B
PR: 7017891010 PRLI: 0001 CONT’D
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
MARKFOR
WK4GA8
0240 QM CO QM SUPPORT CO (
AWCF SSF SMITH BARRACKS BLDG 8338
AULENBACHER STRASSE
BAUMHOLDER 55774
DE
M/F: (TCN) WK4GA862240044
RDD: 239
PROJ: 9GU TP 3
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: V ADV: 2A FC: Z9
SPE2DP-26-T-4664
SECTION B
PR: 7017891010 PRLI: 0001 CONT’D
Need Ship Date:00/00/0000 Original Required Delivery Date:08/18/2026
SPE2DP-26-T-4664 NSN/Part Number: 6505-00-138-7347 Quantity: 1 VI Purchase Request: 7017891010QTY: 1 Delivery: 10 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
